Literature DB >> 17180730

Mechanistic investigation of drug release from asymmetric membrane tablets: effect of media gradients (osmotic pressure and concentration), and potential coating failures on in vitro release.

Mary Tanya Am Ende1, Lee A Miller.   

Abstract

PURPOSE: An asymmetric membrane (AM) tablet was developed for a soluble model compound to study the in vitro drug release mechanisms in challenge conditions, including osmotic gradients, concentration gradients, and under potential coating failure modes. Porous, semipermable membrane integrity may be compromised by a high fat meal or by the presence of a defect in the coating that could cause a safety concern about dose-dumping.
METHODS: The osmotic and diffusional release mechanisms of the AM tablet were independently shut down such that their individual contribution to the overall drug release was measured. Shut off of osmotic and diffusional release was accomplished by performing dissolution studies into receptor solutions with osmotic pressure above the internal core osmotic pressure and into receptor solutions saturated with drug, respectively. The effect of coating failure modes on in vitro drug release from the AM tablet was assessed through a simulated high-fat meal and by intentionally compromising the coating integrity.
RESULTS: The predominant drug release mechanism for the AM tablet was osmotic and accounted for approximately 90-95% of the total release. Osmotic release was shutoff when the receptor media osmotic pressure exceeded 76 atm. Diffusional release of the soluble drug amounted to 5-10% of the total release mechanism. The observed negative in vitro food effect was attributed to the increased osmotic pressure from the high fat meal when compared to the predicted release rates in sucrose media with the same osmotic pressure. This suppression in drug release rate due to a high fat meal is not anticipated to affect in vivo performance of the dosage form, as the rise in pressure is short-lived.
CONCLUSIONS: Drug release from the AM system studied was determined to be robust to varying and extreme challenge conditions. The conditions investigated included varying pH, agitation rate, media osmotic pressure, media saturated with drug to eliminate the concentration gradient, simulated high fat meal, and intentionally placed film coating defects. Osmotic and diffusional shut off experiments suggest that the mechanism governing drug release is a combination of osmotic and diffusional at approximately 90-95% and 5-10%, respectively. In addition, the coating failure mode studies revealed this formulation and design is not significantly affected by a high fat meal or by an intentionally placed defect in the film coating, and more specifically, did not result in a burst of drug release.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180730     DOI: 10.1007/s11095-006-9142-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Elementary osmotic pump.

Authors:  F Theeuwes
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.

Authors:  K Okimoto; A Ohike; R Ibuki; O Aoki; N Ohnishi; T Irie; K Uekama; R A Rajewski; V J Stella
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

3.  Osmotic drug delivery using swellable-core technology.

Authors:  A G Thombre; L E Appel; M B Chidlaw; P D Daugherity; F Dumont; L A F Evans; S C Sutton
Journal:  J Control Release       Date:  2004-01-08       Impact factor: 9.776

4.  Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance.

Authors:  A G Thombre; J R Cardinal; A R DeNoto; D C Gibbes
Journal:  J Control Release       Date:  1999-01-04       Impact factor: 9.776

5.  Mass transport in dissolution kinetics. I: Convective diffusion to assess the role of fluid viscosity under forced flow conditions.

Authors:  K G Nelson; A C Shah
Journal:  J Pharm Sci       Date:  1987-10       Impact factor: 3.534

6.  Factors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent.

Authors:  K Okimoto; A Ohike; R Ibuki; O Aoki; N Ohnishi; R A Rajewski; V J Stella; T Irie; K Uekama
Journal:  J Control Release       Date:  1999-08-05       Impact factor: 9.776

7.  Ionic constituents and osmolality of gastric and small-intestinal fluids after eating.

Authors:  J S Fordtran; T W Locklear
Journal:  Am J Dig Dis       Date:  1966-07

8.  Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.

Authors:  K Okimoto; R A Rajewski; V J Stella
Journal:  J Control Release       Date:  1999-03-08       Impact factor: 9.776

9.  Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin.

Authors:  Philip A Carpino; Bruce A Lefker; Steven M Toler; Lydia C Pan; John R Hadcock; Ewell R Cook; Joseph N DiBrino; Anthony M Campeta; Shari L DeNinno; Kristin L Chidsey-Frink; William A Hada; John Inthavongsay; F Michael Mangano; Michelle A Mullins; David F Nickerson; Oicheng Ng; Christine M Pirie; John A Ragan; Colin R Rose; David A Tess; Ann S Wright; Li Yu; Michael P Zawistoski; Paul A DaSilva-Jardine; Theresa C Wilson; David D Thompson
Journal:  Bioorg Med Chem       Date:  2003-02-20       Impact factor: 3.641

10.  Use of modified ethylcellulose lattices for microporous coating of osmotic tablets.

Authors:  L E Appel; G M Zentner
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

View more
  1 in total

1.  An asymmetric coating composed of gelatin and hydroxyapatite for the delivery of water insoluble drug.

Authors:  Junwu Xiao; Yingchun Zhu; Yanyan Liu; Yi Zeng; Fangfang Xu
Journal:  J Mater Sci Mater Med       Date:  2008-11-20       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.